297 related articles for article (PubMed ID: 27769173)
1. Serum insulin-like growth factor-1 and its binding protein-7: potential novel biomarkers for heart failure with preserved ejection fraction.
Barroso MC; Kramer F; Greene SJ; Scheyer D; Köhler T; Karoff M; Seyfarth M; Gheorghiade M; Dinh W
BMC Cardiovasc Disord; 2016 Oct; 16(1):199. PubMed ID: 27769173
[TBL] [Abstract][Full Text] [Related]
2. HFpEF and HFrEF Display Different Phenotypes as Assessed by IGF-1 and IGFBP-1.
Faxén UL; Hage C; Benson L; Zabarovskaja S; Andreasson A; Donal E; Daubert JC; Linde C; Brismar K; Lund LH
J Card Fail; 2017 Apr; 23(4):293-303. PubMed ID: 27327968
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Prognostic Usefulness of Serum Insulin-Like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection Fraction.
Hage C; Bjerre M; Frystyk J; Gu HF; Brismar K; Donal E; Daubert JC; Linde C; Lund LH
Am J Cardiol; 2018 Jun; 121(12):1558-1566. PubMed ID: 29622288
[TBL] [Abstract][Full Text] [Related]
4. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
[TBL] [Abstract][Full Text] [Related]
5. Twist/untwist parameters are promising evaluators of myocardial mechanic changes in heart failure patients with preserved ejection fraction.
Zhang Y; Li SY; Xie JJ; Wu Y
Clin Cardiol; 2020 Jun; 43(6):587-593. PubMed ID: 32212277
[TBL] [Abstract][Full Text] [Related]
6. Growth differentiation factor-15 is a useful prognostic marker in patients with heart failure with preserved ejection fraction.
Izumiya Y; Hanatani S; Kimura Y; Takashio S; Yamamoto E; Kusaka H; Tokitsu T; Rokutanda T; Araki S; Tsujita K; Tanaka T; Yamamuro M; Kojima S; Tayama S; Kaikita K; Hokimoto S; Ogawa H
Can J Cardiol; 2014 Mar; 30(3):338-44. PubMed ID: 24484911
[TBL] [Abstract][Full Text] [Related]
7. Prognostic usefulness of insulin-like growth factor-binding protein 7 in heart failure with reduced ejection fraction: a novel biomarker of myocardial diastolic function?
Gandhi PU; Gaggin HK; Sheftel AD; Belcher AM; Weiner RB; Baggish AL; Motiwala SR; Liu PP; Januzzi JL
Am J Cardiol; 2014 Nov; 114(10):1543-9. PubMed ID: 25248814
[TBL] [Abstract][Full Text] [Related]
8. Diastolic stress test echocardiography in patients with suspected heart failure with preserved ejection fraction: a pilot study.
Belyavskiy E; Morris DA; Url-Michitsch M; Verheyen N; Meinitzer A; Radhakrishnan AK; Kropf M; Frydas A; Ovchinnikov AG; Schmidt A; Tadic M; Genger M; Lindhorst R; Bobenko A; Tschöpe C; Edelmann F; Pieske-Kraigher E; Pieske B
ESC Heart Fail; 2019 Feb; 6(1):146-153. PubMed ID: 30451399
[TBL] [Abstract][Full Text] [Related]
9. Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction.
Barroso MC; Boehme P; Kramer F; Mondritzki T; Koehler T; Gülker JE; Karoff M; Dinh W
Arq Bras Cardiol; 2017 Nov; 109(5):448-456. PubMed ID: 28977054
[TBL] [Abstract][Full Text] [Related]
10. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.
Santhanakrishnan R; Chong JP; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Richards AM; Lam CS
Eur J Heart Fail; 2012 Dec; 14(12):1338-47. PubMed ID: 22869458
[TBL] [Abstract][Full Text] [Related]
11. The Value of IGF-1 and IGFBP-1 in Patients With Heart Failure With Reduced, Mid-range, and Preserved Ejection Fraction.
Guo S; Gong M; Tse G; Li G; Chen KY; Liu T
Front Cardiovasc Med; 2021; 8():772105. PubMed ID: 35127852
[TBL] [Abstract][Full Text] [Related]
12. Relation of carbohydrate antigen-125 to left atrial remodeling and its prognostic usefulness in patients with heart failure and preserved left ventricular ejection fraction in women.
Hung CL; Hung TC; Liu CC; Wu YJ; Kuo JY; Hou CJ; Yeh HI
Am J Cardiol; 2012 Oct; 110(7):993-1000. PubMed ID: 22728006
[TBL] [Abstract][Full Text] [Related]
13. Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial).
Trippel TD; Van Linthout S; Westermann D; Lindhorst R; Sandek A; Ernst S; Bobenko A; Kasner M; Spillmann F; González A; López B; Ravassa S; Pieske B; Paulus WJ; Díez J; Edelmann F; Tschöpe C
Eur J Heart Fail; 2018 Mar; 20(3):460-470. PubMed ID: 28891228
[TBL] [Abstract][Full Text] [Related]
14. Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction.
Chan MM; Santhanakrishnan R; Chong JP; Chen Z; Tai BC; Liew OW; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong RC; Chai P; Low AF; Richards AM; Lam CS
Eur J Heart Fail; 2016 Jan; 18(1):81-8. PubMed ID: 26497848
[TBL] [Abstract][Full Text] [Related]
15. Insulin-Like Growth Factor-Binding Protein-7 as a Biomarker of Diastolic Dysfunction and Functional Capacity in Heart Failure With Preserved Ejection Fraction: Results From the RELAX Trial.
Gandhi PU; Gaggin HK; Redfield MM; Chen HH; Stevens SR; Anstrom KJ; Semigran MJ; Liu P; Januzzi JL
JACC Heart Fail; 2016 Nov; 4(11):860-869. PubMed ID: 27744089
[TBL] [Abstract][Full Text] [Related]
16. Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction.
Sanders-van Wijk S; van Empel V; Davarzani N; Maeder MT; Handschin R; Pfisterer ME; Brunner-La Rocca HP;
Eur J Heart Fail; 2015 Oct; 17(10):1006-14. PubMed ID: 26472682
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.
Sinning C; Kempf T; Schwarzl M; Lanfermann S; Ojeda F; Schnabel RB; Zengin E; Wild PS; Lackner KJ; Munzel T; Blankenberg S; Wollert KC; Zeller T; Westermann D
Int J Cardiol; 2017 Jan; 227():272-277. PubMed ID: 27838133
[TBL] [Abstract][Full Text] [Related]
18. Pro-Inflammatory Biomarkers in Stable Versus Acutely Decompensated Heart Failure With Preserved Ejection Fraction.
Abernethy A; Raza S; Sun JL; Anstrom KJ; Tracy R; Steiner J; VanBuren P; LeWinter MM
J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29650706
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone is associated with heart failure with preserved ejection fraction.
Bezgin T; Elveran A; Karagoz A; Canga Y; Dogan C
Bratisl Lek Listy; 2016; 117(8):442-7. PubMed ID: 27546695
[TBL] [Abstract][Full Text] [Related]
20. Contributions of Nondiastolic Factors to Exercise Intolerance in Heart Failure With Preserved Ejection Fraction.
Kosmala W; Rojek A; Przewlocka-Kosmala M; Mysiak A; Karolko B; Marwick TH
J Am Coll Cardiol; 2016 Feb; 67(6):659-670. PubMed ID: 26868691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
